Anzeige
Mehr »
Login
Donnerstag, 09.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
NurExone Biologic: Erfahren Sie mehr über den Biotech-Gral!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18.04.Estetrol by Mithra Pharmaceuticals for Female Sexual Dysfunction: Likelihood of Approval
18.04.Estetrol by Mithra Pharmaceuticals for Genitourinary Syndrome of Menopause (GSM): Likelihood of Approval
18.04.Abatacept by Bristol-Myers Squibb for Myocarditis: Likelihood of Approval
18.04.Tezepelumab by Amgen for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
18.04.Paclitaxel albumin bound by Bristol-Myers Squibb for Gallbladder Cancer: Likelihood of Approval
17.04.IGM and Sanofi collaboration will pivot to immunology and inflammation
17.04.Lexeo wins fast track designation for Friedreich's ataxia gene therapy
17.04.Leading providers of washing, disinfection and sterilisation equipment and services
17.04.Alvotech and Teva gain FDA approval of Selarsdi for psoriasis
17.04.Johnson & Johnson reports net earnings of $5.3bn in Q1 2024
17.04.TetraScience and Google Cloud link for AI-driven drug developments
17.04.Medincell and AbbVie make injectable therapy development deal
16.04.Risk adjusted net present value: What is the current valuation of Novo Nordisk's NN-9931?
16.04.Risk adjusted net present value: What is the current valuation of Eli Lilly and Co's LY-3972406?
16.04.Risk adjusted net present value: What is the current valuation of Pfizer's PF-07275315?
16.04.Risk adjusted net present value: What is the current valuation of Enliven Therapeutics's ELVN-002?
16.04.Risk adjusted net present value: What is the current valuation of AstraZeneca's AZD-9574?
16.04.Risk adjusted net present value: What is the current valuation of Novartis's XXB-750?
16.04.Risk adjusted net present value: What is the current valuation of Novo Nordisk's NNC0519-0130?
16.04.Risk adjusted net present value: What is the current valuation of AstraZeneca's Sabestomig?
16.04.Jardiance and Ofev propel Boehringer's human pharma sales
16.04.Acorda loses Nasdaq listing to cap biotech's end
16.04.Harnessing artificial intelligence and digital technologies across the biopharma value chain
16.04.Two major breakthroughs in Fragile X Syndrome treatments
16.04.Leading API biologics (cell, gene, vaccine and virus) companies in contract manufacturing